IN190388B - - Google Patents

Info

Publication number
IN190388B
IN190388B IN2930DE1998A IN190388B IN 190388 B IN190388 B IN 190388B IN 2930DE1998 A IN2930DE1998 A IN 2930DE1998A IN 190388 B IN190388 B IN 190388B
Authority
IN
India
Prior art keywords
active compound
biologically active
vesicles
mlcvs
multilamellar
Prior art date
Application number
Other languages
English (en)
Inventor
Lawrence Boni
Michael Batenjany
Stella Gevantmakher
Original Assignee
Biomira Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Usa Inc filed Critical Biomira Usa Inc
Publication of IN190388B publication Critical patent/IN190388B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes
    • A61K9/1278Post-loading, e.g. by ion or pH gradient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906Drug delivery
    • Y10S977/907Liposome
IN2930DE1998 1997-10-01 1998-01-01 IN190388B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6060697P 1997-10-01 1997-10-01

Publications (1)

Publication Number Publication Date
IN190388B true IN190388B (de) 2003-07-26

Family

ID=22030591

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2930DE1998 IN190388B (de) 1997-10-01 1998-01-01

Country Status (9)

Country Link
US (1) US6544549B1 (de)
EP (1) EP1019026B1 (de)
JP (1) JP2001517693A (de)
AT (1) ATE286717T1 (de)
AU (1) AU745000B2 (de)
CA (1) CA2305533C (de)
DE (1) DE69828624T2 (de)
IN (1) IN190388B (de)
WO (1) WO1999016426A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1857112B1 (de) * 2005-03-09 2013-05-15 Sunstar Inc. Mittel gegen krebs mit phytosterol-haltigen liposomen
US7662405B2 (en) * 2005-08-09 2010-02-16 The Research Foundation Of State University Of New York Compositions and methods of preparation of liposomal microparticulate IL-12
US8597678B2 (en) 2005-12-30 2013-12-03 Dermazone Solutions, Inc. Nanolipidic particles
US20140271782A1 (en) 2013-03-15 2014-09-18 Dermazone Solutions, Inc. Method for preparing nanolipids with encapsulated alcohol
EP3936122A1 (de) 2008-11-24 2022-01-12 Massachusetts Institute Of Technology Verfahren und zusammensetzung zur lokalen wirkstoffabgabe
US20100323018A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Branched DNA/RNA monomers and uses thereof
US20100324124A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Compositions and methods relating to DNA-based particles
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
BR112012023501A2 (pt) 2010-03-19 2016-05-31 Massachusetts Inst Technology vesículas lipídicas multilamelares, composição farmacêutica e método
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
CN102654505A (zh) * 2012-05-16 2012-09-05 江苏省原子医学研究所 一种检测il-2-hsa的时间分辨荧光免疫分析试剂盒及其检测方法
US10639367B2 (en) * 2012-11-02 2020-05-05 Cytuvax Composition comprising cytokine macro-aggregates
US9770415B2 (en) * 2012-11-27 2017-09-26 Southwest Research Institute Delivery substrates from aligned polymer biomaterials for tissue repair
ES2904276T3 (es) 2013-09-27 2022-04-04 Massachusetts Inst Technology Nanoestructuras de proteínas biológicamente activas sin vehículo
DK3291797T3 (da) 2015-05-04 2020-09-21 Versantis AG Metode til forberedelse af transmembran ph-gradiente vesikler
JP6887685B2 (ja) 2015-08-12 2021-06-16 マサチューセッツ インスティテュート オブ テクノロジー ナノ粒子の細胞表面共役
JP7185530B2 (ja) 2016-06-13 2022-12-07 トルク セラピューティクス, インコーポレイテッド 免疫細胞機能を促進するための方法および組成物
CN111432836A (zh) 2017-09-05 2020-07-17 转矩医疗股份有限公司 治疗性蛋白质组合物及其制备和使用方法
US20200078427A1 (en) 2018-09-06 2020-03-12 NuVessl, Inc. Cannabis Sativa Derived Formulation for Transmucosal and Transdermal Delivery
US20200188298A1 (en) 2018-12-14 2020-06-18 NuVessl, Inc. Method For Using Composition With Enhanced Passenger Molecule Loading
JP2023512707A (ja) * 2020-02-05 2023-03-28 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド Rna負荷ナノ粒子およびがんの治療のためのそれらの使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04356421A (ja) 1991-03-06 1992-12-10 Green Cross Corp:The プロスタグランジン類含有脂肪小体組成物
WO1997029769A1 (en) * 1996-02-16 1997-08-21 Biomira Usa Inc. Vaccine for b-cell malignancies

Also Published As

Publication number Publication date
US6544549B1 (en) 2003-04-08
EP1019026B1 (de) 2005-01-12
DE69828624D1 (de) 2005-02-17
AU9680098A (en) 1999-04-23
JP2001517693A (ja) 2001-10-09
WO1999016426A2 (en) 1999-04-08
EP1019026A2 (de) 2000-07-19
CA2305533A1 (en) 1999-04-08
WO1999016426A3 (en) 1999-06-17
ATE286717T1 (de) 2005-01-15
AU745000B2 (en) 2002-03-07
DE69828624T2 (de) 2005-12-22
CA2305533C (en) 2009-12-01

Similar Documents

Publication Publication Date Title
IN190388B (de)
ATE341310T1 (de) Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
WO2000045791A3 (en) Method for controlling liposome size
ES8607906A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas conteniendo liposomas unilamilares
AU8141891A (en) Unilamellar vesicles
NZ334561A (en) Preparation of multivesicular liposomes for controPreparation of multivesicular liposomes for controlled release of active agents lled release of active agents
AU6036596A (en) Process for making liposome preparation
HUP9802578A3 (en) Phenylacetic acid derivatives, process and intermediates for producing them, fingicide, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients and use thereof
CA2108288A1 (en) Liposomal cyclosporin formulation and process for the preparation thereof
CA2227761A1 (en) Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
WO2003000227A3 (en) A method for preparation of vesicles loaded with biological material and different uses thereof
ES2074878T3 (es) Polvo preliposomal de polieno liposomal y metodo para su preparacion.
JP2001517693A5 (de)
CA2187748A1 (en) Fusogenic liposomes and methods of making and using same
MY131524A (en) Liposomal itraconazole formulations
CA2202103A1 (en) Method for preparing closed vesicles
GB2303791A (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
AU651969B2 (en) Process for the production of aqueous liposome suspensions containing active ingredients
EP0382777A4 (en) Aqueous preparation of liposome composition
JPS5344559A (en) New urethanes and their preparation
TH58479B (th) สารผสมสำหรับใช้ทางปากต้านแบคทีเรียชนิดลิวพูโลนที่ถูกไฮโดรจีเนตและคงตัว